QNRX News and Press, Quoin Pharmaceuticals Ltd. From 08/18/22

Initiates clinical trial evaluating lead product candidate, QRX003 for Netherton Syndrome Expands number of commercial partnerships to eight, covering 60 countries Signs Research Agreement to develop a product for the treatment of scleroderma Closes $16.8 million public ...

Gainers: Hill International ( HIL ) +61% . Laird Superfood ( LSF ) +25% Confirms Receipt of Unsolicited Offer. Quoin Pharmaceuticals ( QNRX ) +26% . Bed Bath & Beyond ( BBBY ) +24% jumps nearly 30% as meme stock rally rolls on . ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com We’ve got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about! Moving stocks this morning are reverse stock splits, ...

ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial re...

ASHBURN, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced the closing of its previously announced p...

Gainers: CinCor Pharma CINC +66% . Karuna Therapeutics KRTX +61% . 23andMe ( ME ) +22% . Cerevel Therapeutics ( CERE ) +20% . Quoin Pharmaceuticals ( QNRX ) +16% . Losers: Reata Pharmaceuticals RETA -31% . uniQure QUR...

Bonso Electronics International ( BNSO ) +158% . MAGIC EMPIRE GLOBAL ( MEGL ) +101% . Karuna Therapeutics ( KRTX ) +50% as schizophrenia trial meets key goal. Bed Bath & Beyond  ( BBBY ) +38% . Iveda Solutions ( IVDA ) +...

Quoin Pharmaceuticals ( NASDAQ: QNRX ) stock fell ~65% on Aug. 5 after the company priced an offering to raise $16.8M in gross proceeds. The company is offering 11.05B ordinary shares represented by 2.21M American Depositary Shares (ADSs) at $5.00 per ADS and ...

Quoin Pharmaceuticals ( NASDAQ: QNRX ) priced its reasonable best efforts public offering of 11.05B shares represented by 2.21M ADS at purchase price of $5/ADS and pre-funded warrants to purchase 5.75B shares represented by 1.15M ADS at a per pre-funded warrant price of $4.999...

Gainers: Allied Healthcare Products ( AHPI ) +30% . Progyny ( PGNY ) +28% . Kazia Therapeutics ( KZIA ) +21% . Selecta Biosciences ( SELB ) +18% . Sensus Healthcare ( SRTS ) +17% . Losers: Quoin Pharmaceuticals ( QNRX...